$170 Million is the total value of KNOTT DAVID M's 135 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 85.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FSK | New | FS KKR Capital Corp. | $6,268,000 | – | 395,175 | +100.0% | 3.68% | – |
| HZNP | Buy | Horizon Therapeutics Public Ltd. Company | $2,915,000 | +43.6% | 37,531 | +2.7% | 1.71% | +54.3% |
| KDMN | Buy | Kadmon Holdings, Inc. | $2,399,000 | +7.1% | 612,000 | +39.9% | 1.41% | +15.1% |
| EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $2,241,000 | -11.5% | 275,348 | +4.4% | 1.32% | -4.8% |
| ZGNX | Buy | Zogenix, Inc. | $2,021,000 | -29.1% | 112,707 | +6.7% | 1.19% | -23.8% |
| AUPH | Buy | Aurinia Pharmaceuticals Inc. | $1,983,000 | +6.3% | 134,600 | +17.2% | 1.16% | +14.1% |
| XENE | Buy | Xenon Pharmaceuticals Inc. | $1,959,000 | -7.6% | 177,000 | +4.7% | 1.15% | -0.7% |
| VAPO | New | Vapotherm, Inc. | $1,421,000 | – | 49,000 | +100.0% | 0.83% | – |
| ALXN | New | Alexion Pharamaceuticals, Inc. | $1,373,000 | – | 12,000 | +100.0% | 0.81% | – |
| TGTX | Buy | TG Therapeutics Inc. | $1,359,000 | +480.8% | 50,773 | +323.1% | 0.80% | +522.7% |
| MDWT | New | Midwest Holding Inc. | $1,247,000 | – | 83,344 | +100.0% | 0.73% | – |
| QURE | Buy | uniQure N.V. | $1,142,000 | +24.5% | 31,000 | +52.3% | 0.67% | +33.7% |
| FGEN | New | FibroGen, Inc. | $811,000 | – | 19,715 | +100.0% | 0.48% | – |
| SBBP | Buy | Strongbridge Biopharma PLC | $781,000 | -30.2% | 372,000 | +25.7% | 0.46% | -25.0% |
| GILD | New | Gilead Sciences, Inc. | $695,000 | – | 11,000 | +100.0% | 0.41% | – |
| RDUS | Buy | Radius Health Inc. | $545,000 | -7.2% | 48,034 | +11.6% | 0.32% | 0.0% |
| AAPL | Buy | Apple Inc. | $486,000 | +26.6% | 4,200 | +300.0% | 0.28% | +35.7% |
| VRCA | Buy | Verrica Pharmaceuticals, Inc. | $357,000 | +116.4% | 46,125 | +208.6% | 0.21% | +132.2% |
| CYTK | Buy | Cytokinetics, Incorporated | $343,000 | +63.3% | 15,837 | +77.5% | 0.20% | +74.8% |
| TARA | Buy | Protara Therapeutics, Inc. | $134,000 | +19.6% | 7,948 | +107.2% | 0.08% | +29.5% |
| IBB | New | iShares Nasdaq Biotechnology ETF | $135,000 | – | 1,000 | +100.0% | 0.08% | – |
| ALXO | New | ALX Oncology. Inc | $113,000 | – | 3,000 | +100.0% | 0.07% | – |
| CRDF | New | Cardiff Oncology, Inc. | $71,000 | – | 5,000 | +100.0% | 0.04% | – |
| ACIU | New | AC Immune SA | $26,000 | – | 5,309 | +100.0% | 0.02% | – |
| BMYRT | New | Bristol-Myers Squibb Company - CVR | $12,000 | – | 5,200 | +100.0% | 0.01% | – |
| OXYWS | New | Occidental Pete Corp wts exp 8/3/27 | $0 | – | 370 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.